BioAtla, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $300,000 |
| Operating income | -$59.3M | -$73.9M | -$129.7M | -$108.1M | -$96.4M |
| Operating expenses | $61.3M | $84.9M | $129.7M | $108.1M | $96.7M |
| Cash from operations | -$48.2M | -$71.9M | -$104.0M | -$90.4M | -$62.2M |
| Capital expenditure | — | — | $0 | $1,000 | $1,000 |
| Free cash flow | — | — | -$104.0M | -$90.4M | -$62.2M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $13.8M | $52.4M | $119.7M | $225.7M | $254.4M |
| Total liabilities | $50.0M | $38.2M | $49.0M | $45.4M | $43.6M |
Shares outstanding 1.7M · Free float 90.6%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.